Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
-
Zhong Xi Yi Jie He Xue Bao · Apr 2008
Editorial[How to assess the quality of systematic review and meta-analysis].
Evidence-based medicine advocates that decision making should be based on the adequate evidence. High quality systematic review is an important source of information for clinicians, patients, governments and other decision makers in decision making. If reviewers couldn't master the correct method of systematic review or meta-analysis was misused, the inaccurate, biased or misleading outcomes would be produced. So understanding of the methods of evaluating the quality of systematic review and meta-analysis is helpful to make good use of the review's information.
-
Zhong Xi Yi Jie He Xue Bao · Apr 2008
[Evaluation of Chinese version of the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire].
To evaluate the effectiveness of the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) questionnaire in measuring the quality of life in patients with primary hepatic carcinoma (PHC) in China. ⋯ The FACT-Hep questionnaire can measure the quality of life in patients with PHC with good reliability, validity and responsiveness; it can be used in assessing the disease-specific health-related quality of life of patients with hepatobiliary cancers.
-
Zhong Xi Yi Jie He Xue Bao · Apr 2008
[Effects of Xuefu Zhuyu Capsule on endothelin-1 release in myocardium and vascular endothelium and nitric oxide/nitric oxide synthase system of swines after acute myocardial infarction and reperfusion].
To observe the effects of Xuefu Zhuyu Capsule (XFZYC), a compound traditional Chinese herbal medicine, on endothelin-1 (ET-1) release in myocardium and vascular endothelium and nitric oxide (NO)/nitric oxide synthase (NOS) system of swines after acute myocardial infarction (AMI) and reperfusion, and to explore the action mechanisms of XFZYC in improving the endothelium function. ⋯ The endothelium injury may be one of the important mechanisms for no-reflow phenomenon. XFZYC may reduce the no-reflow by protecting endothelium cells.